SCHEMBL1968530

SCHEMBL1968530

COC(=O)CS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10663339 0.82 GAA (0.44)
SCHEMBL10622350 0.80 TSHR (0.52)
SCHEMBL5160723 0.80 ALDH1A1 (0.39)
SCHEMBL1123070 0.78
SCHEMBL27612507 0.77 MGAM (0.55)
SCHEMBL703295 0.76
SCHEMBL13457619 0.76
SCHEMBL15800899 0.76 TSHR (0.46)
SCHEMBL8375840 0.76 TSHR (0.46)
SCHEMBL5328813 0.76 TSHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541830-A1 PROCESS FOR PRODUCING POLYURETHANE FOAM Covestro Deutschland AG (DE) 2025-04-23 EP claimed
CN-105384614-B A kind of synthetic method of trimethyl orthoacetate 江苏扬农化工股份有限公司 2018-03-23 CN claimed
CN-105384614-A Trimethyl orthoacetate synthesis method JIANGSU YANGNONG CHEMICAL CO 2016-03-09 CN claimed
US-20250368666-A1 INDAZOLE COMPOUNDS TYRA BIOSCIENCES INC (US) 2025-12-04 US disclosed
US-20250368616-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) 2025-12-04 US disclosed
US-20250353820-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS NOVARTIS AG (CH) 2025-11-20 US disclosed
US-20250289801-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION 2025-09-18 US disclosed
US-20250282781-A1 APOL1 INHIBITORS AND METHODS OF USE HERCULES CAPITAL, INC., AS AGENT 2025-09-11 US disclosed
EP-4359400-B1 SALT AND CRYSTAL FORM OF AN AZETIDINYL SUBSTITUTED ISOQUINLINE ACTING AS EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR FOR THE TREATMENT OF CANCER BLUEPRINT MEDICINES CORP (US) 2025-07-02 EP disclosed
US-12344610-B2 APOL1 inhibitors and methods of use MAZE THERAPEUTICS, INC. (US) 2025-07-01 US disclosed
US-20250206718-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-06-26 US disclosed
US-5612355-A Phenyl amidine lactones useful as platelet aggregation inhibitors G. D. SEARLE & CO. (US) 1997-03-18 US disclosed
US-5510350-A USEFUL IN TREATMENT OR PROPHYLAXIS OF DEPRESSION AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS GLAXO GROUP LIMITED (GB) 1996-04-23 US disclosed
US-5504106-A Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors G. D. SEARLE & CO. (US) 1996-04-02 US disclosed
US-5340810-A Useful in the treatment and prophylaxis of depression and other disorders of the central nervous system GLAXO GROUP LIMITED (GB) 1994-08-23 US disclosed
CN-1076195-A N-Benzoylbenzene sulfonamide derivatives GLAXO GROUP LTD (GB) 1993-09-15 CN disclosed
CN-1071919-A N-Benzoylbenzene sulfonamide derivatives GLAXO GROUP LTD (GB) 1993-05-12 CN disclosed
EP-0533268-A1 Benzanilide derivatives as 5-HT1D antagonists GLAXO GROUP LIMITED (GB) 1993-03-24 EP disclosed
US-4822814-A PREVENTING OR TREATING LIVER DISORDERS; FUNGICIDES; OR PREVENTING ACCUMULATION OF FAT HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 1989-04-18 US disclosed
EP-0242061-A2 New 1,3-dithiol-2-ylidene-alkylsulfonylacetates and their uses HOKKO CHEMICAL INDUSTRY CO., LTD (JP) 1987-10-21 EP disclosed